Panic Disorders Market Developments and Opportunities Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Panic Disorders Market Between 2026 And 2030?

The market size for panic disorders has experienced strong growth in recent years. It is projected to increase from $11.15 billion in 2025 to $11.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.3%. This expansion observed during the historic period can be attributed to factors such as limited awareness of panic disorders, a reliance on traditional in-person therapy, the high cost of medications, a fragmented mental healthcare infrastructure, and the low adoption of digital therapy tools.

The panic disorders market size is anticipated to experience robust expansion over the coming years. This market is projected to reach $15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.3%. The expected growth during the forecast period is primarily driven by factors such as the rising incidence of anxiety and panic disorders, increased adoption of telepsychiatry, advancements in virtual reality and neurofeedback therapies, the expansion of online pharmacy and hospital distribution channels, and a growing demand for personalized mental healthcare plans. Key trends identified for the forecast timeframe include the increasing embrace of telepsychiatry and mobile mental health applications, the integration of virtual reality therapy for anxiety disorders, greater utilization of biofeedback and neurofeedback techniques, the development of individualized medication regimens for panic disorders, and the enlargement of mental healthcare facilities and hospital services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

What Leading Drivers Are Supporting The Panic Disorders Market Expansion?

The expanding adoption of telehealth is projected to fuel the growth of the panic disorders market in the future. Telehealth employs electronic communication methods, including videoconferencing, phone calls, and secure messaging, to offer healthcare services and medical consultations remotely. It enables psychotherapy and counseling services for those affected by panic disorders. Through secure videoconferencing platforms, therapists are able to conduct individual therapy sessions, group therapy, or support groups. As an illustration, FAIR Health Inc., a US-based non-profit organization, reported in April 2023 a 7.3% national surge in telehealth usage, climbing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the growing use of telehealth is boosting the expansion of the panic disorders market.

Which Segment Classifications Are Used In The Panic Disorders Market Segment Analysis?

The panic disorders market covered in this report is segmented –

1) By Treatment Type: Pharmacotherapies, Psychotherapeutic Interventions, Digital Or Tech-Enabled Therapies

2) By Disorder Type: Panic Disorder Without Agoraphobia, Panic Disorder With Agoraphobia, Mild Panic Disorder, Moderate Panic Disorder, Severe Panic Disorder, Panic Disorder With Comorbidities

3) By Age Group: Children And Adolescents, Adults, Elderly

4) By End User: Hospitals, Specialty Mental Health Clinics, Primary Care Clinics, Telehealth And Digital Platforms, Home Healthcare Services

Subsegments:

1) By Pharmacotherapies: Antidepressants, Benzodiazepines, Beta-Blockers

2) By Psychotherapeutic Interventions: Cognitive Behavioral Therapy (CBT), Exposure Therapy, Psychodynamic Therapy, Group And Family Therapy

3) By Digital Or Tech-Enabled Therapies: Mental Health Apps, Telepsychiatry Or Teletherapy, Virtual CBT Programs

What Emerging Trends Are Seen In The Panic Disorders Market?

Leading companies active in the panic disorder market are focusing on the development of advanced pharmaceutical products, particularly extended-release capsules, to strengthen their market position. Extended-release capsules are formulations designed to release active ingredients gradually over an extended period, typically 12 to 24 hours, ensuring sustained therapeutic effects for conditions requiring continuous medication. For example, in May 2023, Granules India Ltd., an India-based pharmaceutical company, received Abbreviated New Drug Application (ANDA) approval from the US Food & Drug Administration (USFDA) for its venlafaxine hydrochloride extended-release capsules. This product is bioequivalent to the reference-listed drug Effexor XR extended-release capsules by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are used to treat conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They work by increasing serotonin and norepinephrine levels in the brain, with a typical starting dose of 75 mg per day that can be adjusted as needed.

Which Firms Are Contributing To The Panic Disorders Market Ecosystem?

Major companies operating in the panic disorders market are F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc, Sun Pharmaceutical Industries Ltd, H. Lundbeck A/S, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc, Sumitomo Pharma Co Ltd, LIFECARE NEURO PRODUCTS LTD, Merck & Co Inc, Johnson & Johnson, Novartis AG, Otsuka Pharmaceutical Co Ltd.

Get The Full Panic Disorders Market Report:

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Where Is The Panic Disorders Market Primarily Concentrated By Region?

North America was the largest region in the panic disorders market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Panic Disorders Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Browse Through More Reports Similar to the Global Panic Disorders Market 2026, By The Business Research Company

Generalized Anxiety Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Migraine Treatment Market Report

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Catalepsy Treatment Market Report

https://www.thebusinessresearchcompany.com/report/catalepsy-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795